Couple suing OptumRx over son's death

Couple suing OptumRx over son's death, alleging his asthma meds rose by almost $500
A Wisconsin couple are suing Walgreens and Optum Rx over their son's death, claiming he was unable to afford a sudden spike of cost in his asthma medication. The suit was submitted in federal court by William and Shanon Schmidtknecht of Poynette, Wis. on Jan. 21, a year to the date that their son, 22-year-old Cole Schmidtknecht, died.
Wisconsin couple sues Walgreens, Optum Rx, saying son died after sudden $500 price spike for asthma meds
Shanon and William Schmidtknecht, of Poynette, say their 22-year-old son Cole was told the cost had jumped from $66 to $539 out-of-pocket. He tried to manage his condition with his rescue inhaler but suffered a fatal asthma attack days later.
Couple sues Walgreens and Optum Rx over son’s death after $500 price rise for asthma meds
A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication
Wisconsin couple sues Walgreens, Optum Rx over son's death
A Wisconsin couple has filed a lawsuit against pharmacy benefit manager Optum Rx and Walgreens, alleging their son's death was linked to a sudden price increase in his asthma medication. The lawsuit,
Man dies after inhaler cost jumps $500; family sues Walgreens, Optum Rx
A Wisconsin couple is suing Walgreens and Optum Rx in connection to their adult son's death. The lawsuit alleges the pharmacy benefits management company violated state law by raising the cost of the medication without a valid medical reason and failing to provide 30 days' advance notice of drug price increases.
Man dies of asthma attack after inhaler cost skyrockets to more than $500
United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...
inc422h
Zeta Nets $50 Mn From Optum, Valuation Jumps To $2Bn
Banking tech unicorn Zeta has secured $50 Mn (INR 434.3 Cr) in a fresh funding round from Optum at a valuation of $2 Bn ...
When the Cost of His Asthma Inhaler Went Up $500, His Parents Claim He Couldn't Pay. Two Weeks Later He Was Dead at 22
Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase. Two weeks ...
Zeta secures $50 million in fresh funding from US-based Optum
The SoftBank-backed banking tech startup will be valued at $2 billion after this investment, up from around $1.45 billion ...
Government Executive8h
Protecting taxpayer dollars
The Government spends more than $1 trillion on healthcare every year through large programs such as Medicare, Medicaid, ...
Zeta valued at $2B in new funding
Zeta, a provider of banking software to banks and fintech startups, has raised $50 million from a strategic investor at a $2 billion valuation. The new investment from American healthcare company ...
STAT7d
The first shot taken at Medicaid, and Optum’s wellness visit ad
The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.
Fierce Healthcare8d
Optum study: Accountable Medicare Advantage models reduce admissions, ER visits
Medicare Advantage patients treated in value-based care models saw better outcomes than those treated in fee-for-service ...
Wisconsin man dies after inhaler cost jumps $500, according to family's lawsuit
A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a ...
Banking tech startup Zeta raises $50 million in fresh funding; valuation rises to $2 billion
The SoftBank-backed banking tech startup will be valued at $2 billion after this investment, up from around $1.45 billion ...